Stock news
2 stories match “AMIX”
Market narrative auditsAutonomix Medical, Inc. (NASDAQ: AMIX) Gets a Clearer FDA PathThe company sees a potential 15-month route to initial clearance, but its filing says it needs $25 million to $30 million to reach commercialization. AMIX · OptimistFi Research Desk ·
Market narrative auditsIs the Collectibles Pivot Paying Off for GameStop Corp. (NYSE: GME)?Collectibles are growing and margins have improved. Falling total sales and a mixed cash-flow picture show what the retail pivot still needs to prove. GME · OptimistFi Research Desk ·

